Mannkind (MNKD) Change in Receivables (2015 - 2026)
Mannkind (MNKD) posted quarterly Change in Receivables of -$10.3 million for Q1 2026, down 160.19% year-over-year from $17.1 million in Q1 2025, and down 1159.49% quarter-over-quarter from -$817000.0 in Q4 2025.
Mannkind (MNKD) Change in Receivables (2015 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Change in Receivables for 12 consecutive years, with -$10.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 160.19% year-over-year to -$10.3 million; the TTM figure through Mar 2026 stood at -$22.6 million (down 351.71% YoY), while the FY2025 annual figure was $4.8 million, up 279.56% from the prior year.
- Change in Receivables declined to -$10.3 million in Q1 2026 per MNKD's latest filing, from -$817000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $17.1 million in Q1 2025 and bottomed at -$10.3 million in Q1 2026.
- Historically, Change in Receivables has averaged $75411.8 across 5 years, with a median of -$817000.0 in 2025.
- Annual changes were most pronounced in 2022 — Change in Receivables surged 848.68% — and 2023, when it sank 170.51%.
- Mannkind's Change in Receivables stood at -$6.7 million in 2022, then dropped by 10.07% to -$7.4 million in 2023, then advanced by 13.39% to -$6.4 million in 2024, then soared by 87.19% to -$817000.0 in 2025, then slumped by 1159.49% to -$10.3 million in 2026.
- Business Quant data shows MNKD's Change in Receivables at -$10.3 million in Q1 2026, -$817000.0 in Q4 2025, and -$9.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | 15.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.07 Mn |
| Jun 30, 2026 | 15.07 Mn |
| Mar 31, 2026 | -10.29 Mn |
| Mar 31, 2026 | -10.29 Mn |
| Dec 31, 2025 | -817,000.00 |
| Dec 31, 2025 | -817,000.00 |
| Sep 30, 2025 | -9.76 Mn |
| Sep 30, 2025 | -9.76 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Mar 31, 2025 | 17.10 Mn |
| Dec 31, 2024 | -6.38 Mn |
| Dec 31, 2024 | -6.38 Mn |
| Sep 30, 2024 | -5.16 Mn |
| Sep 30, 2024 | -5.16 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Mar 31, 2024 | 5.46 Mn |